Drug Shortage Report for SYNACTHEN DEPOT
Report ID | 72327 |
Drug Identification Number | 00253952 |
Brand name | SYNACTHEN DEPOT |
Common or Proper name | Tetracosactide Zinc Injection |
Company Name | ATNAHS PHARMA UK LIMITED |
Market Status | DORMANT |
Active Ingredient(s) | TETRACOSACTIDE |
Strength(s) | 1MG |
Dosage form(s) | SUSPENSION |
Route of administration | INTRAMUSCULAR |
Packaging size | 1 mL ampoule |
ATC code | H01AA |
ATC description | ANTERIOR PITUITARY LOBE HORMONES AND ANALOGUES |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2019-02-28 |
Actual start date | |
Estimated end date | Unknown |
Actual end date | |
Shortage status | Actual shortage |
Updated date | 2019-04-12 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | SOVEREIGN HOUSE, MILES GRAY ROAD BASILDON, ESSEX GREAT BRITAIN SS14 3FR |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2019-04-12 | French | Compare |
v5 | 2019-04-12 | English | Compare |
v4 | 2019-03-01 | English | Compare |
v3 | 2019-01-15 | French | Compare |
v2 | 2019-01-15 | English | Compare |
v1 | 2019-01-15 | English | Compare |
Showing 1 to 6 of 6